Transplantation, HomologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousTissue DonorsGraft SurvivalGraft vs Tumor EffectHematologic NeoplasmsHistocompatibility TestingLeukemiaBusulfanWhole-Body IrradiationRecurrenceTreatment OutcomeKidney TransplantationRemission InductionLeukemia, Myeloid, AcuteRetrospective StudiesGraft RejectionSurvival AnalysisTime FactorsGranulocyte Colony-Stimulating FactorCombined Modality TherapyTransplantsImmunosuppressive AgentsDisease-Free SurvivalSurvival RateHeart TransplantationTransplantationIsoantigensImmunosuppressionTransplantation ChimeraLung TransplantationTransplantation ImmunologyTransplantation, IsogeneicLymphocyte Culture Test, MixedT-LymphocytesCyclosporineHistocompatibilityCytomegalovirus InfectionsStem Cell TransplantationTacrolimusSkin TransplantationGraft vs Leukemia EffectTissue and Organ ProcurementLiving DonorsTransplantation ToleranceHLA AntigensPostoperative ComplicationsGraft vs Host ReactionMice, Inbred C57BLMice, Inbred BALB CLymphocyte ActivationLymphocyte DepletionAcute DiseaseImmunocompromised HostWaiting ListsFetal Tissue TransplantationPeripheral Blood Stem Cell TransplantationAntilymphocyte SerumFollow-Up StudiesAnemia, AplasticMycophenolic AcidMyeloablative AgonistsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytotoxicity, ImmunologicIsoantibodiesCytomegalovirusLeukocyte TransfusionSpleenImmune ToleranceTransplantation, HeterotopicIslets of Langerhans TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation ChimeraRisk FactorsVidarabineGanciclovirDendritic CellsChimerismOpportunistic InfectionsCadaverAllograftsLymphocytesKidney Failure, ChronicMyelodysplastic SyndromesLymphoproliferative DisordersLiver FailureBlood TransfusionBlood Transfusion, AutologousProspective StudiesMycosesT-Lymphocytes, CytotoxicHematologic DiseasesCord Blood Stem Cell TransplantationMice, Inbred StrainsFlow CytometryHistocompatibility Antigens